EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lifetime prevalence of cancer in Germany between 2010 and 2019: An analysis based on aggregated data

Kira Baginski iD, Dina Voeltz iD, Claudia Hornberg, Claudia Kohring iD, Annika Hoyer iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0334637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Kira Baginski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics and Medical Biometry, Medical School OWL, Bielefeld University, Bielefeld, Germany. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Many cancer survivors (i.e., individuals alive who have been diagnosed with cancer at some point in their lives) remain under surveillance by doctors and medical professionals regardless of the outcome of their treatment as they face the risk of recurrence and/or encounter symptoms and other health-related issues. With advancements in cancer early detection, diagnostics, and treatment strategies, along with an increasingly older population, the number of cancer survivors is steadily increasing. Since information on epidemiological indicators of cancer survivors is limited in Germany, the present study aims to estimate its prevalence between 2010 and 2019.

Methods

The annual age- and sex-specific lifetime prevalence of cancer was estimated using a partial differential equation. The calculation was based on comprehensive data obtained from the Centre for Cancer Registry Data (Zentrum für Krebsregisterdaten, ZfKD), the Central Research Institute of Ambulatory Health Care in Germany (Zentralinstitut für die kassenärztliche Versorgung, Zi), and the German Federal Statistical Office.

Results

Our estimates indicate a rise in lifetime prevalence of cancer between 2010 and 2019 across all ages up to 85, particularly pronounced among older individuals. By 2019, the highest prevalence was estimated to be 49% of males and 28% of females at age 85. In contrast, childhood cancer was relatively rare, affecting less than 0.3% of girls and boys until the age of 18. Generally, the prevalence of cancer was higher among males than females. Overall, the number of cancer survivors aged up to 85 was estimated to increase from 2.51 million in 2010 to over 5.07 million in 2019.

Conclusions

The findings indicate a substantial rise in the lifetime prevalence of cancer in 2019 compared to 2010. Considering a cancer patient as cured based on a specific timeframe may lead to an underestimation of the future demand for healthcare resources.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansGermanyMaleFemalePrevalenceAgedMiddle AgedAdultAged, 80 and overAdolescentChildYoung AdultRegistriesChild, PreschoolInfantCancer SurvivorsInfant, Newborn

Autor:innen und Institutionen

  • Biostatistics and Medical Biometry, Medical School OWL, Bielefeld University, Bielefeld, Germany.
  • Department of Environmental Health Sciences, Medical School OWL, Bielefeld University, Bielefeld, Germany.
  • Department of Epidemiology and Health Care Atlas, Central Research Institute of Ambulatory Health Care in Germany, Berlin, Germany.

ORCID-Profile: Kira Baginski, Dina Voeltz, Claudia Kohring, Annika Hoyer

Zitieren

APA

Baginski, K., Voeltz, D., Hornberg, C., Kohring, C., & Hoyer, A. (2025). Lifetime prevalence of cancer in Germany between 2010 and 2019: An analysis based on aggregated data. PLOS One. https://doi.org/10.1371/journal.pone.0334637

Vancouver

Baginski K, Voeltz D, Hornberg C, Kohring C, Hoyer A. Lifetime prevalence of cancer in Germany between 2010 and 2019: An analysis based on aggregated data. PLOS One. 2025. doi:10.1371/journal.pone.0334637

BibTeX
@article{Baginski2025,
  author = {Baginski, Kira and Voeltz, Dina and Hornberg, Claudia and Kohring, Claudia and Hoyer, Annika},
  title = {Lifetime prevalence of cancer in Germany between 2010 and 2019: An analysis based on aggregated data},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0334637}
}
Kostenlos starten →